Kaleidex, a fast-growing specialist in advanced medical device development and manufacturing, announced the appointment of Gavin Meadows as Chief Executive Officer.
Gavin joins Kaleidex from Johnson & Johnson MedTech, where he served as General Manager, leading the UK orthopaedics business, a portfolio exceeding $300M. He brings a proven track record in driving top-line growth, optimising product portfolios, strengthening pricing discipline, and delivering consistent commercial performance.
With extensive international experience across the UK and Ireland, Central and Eastern Europe, and the Middle East and Africa, Gavin has successfully led organisations in both direct and distributor-led markets. A former Olympic athlete, he is recognised for his clarity, decisiveness and ability to deliver results across diverse markets and cultures.
Jon Lynch, Kaleidex’s Chief Financial Officer, commented: “Over the past year, Kaleidex has continued to grow in scale, capability and ambition. Gavin’s experience and leadership will allow Kaleidex to further strengthen our position as a trusted partner for our customers and accelerate our growth.”
Gavin’s appointment marks a significant step for Kaleidex as the Group continues to scale. This follows recent senior additions to Kaleidex’s commercial team, underpinning Kaleidex’s commitment to become the first-choice manufacturing partner for medical device innovators.
On his introduction to the Kaleidex team, Gavin said:
“I’m thrilled to be joining Kaleidex at such an exciting point in its journey. This is an ambitious company which unites expertise and innovation and has a deep commitment to supporting growth throughout all sites. I look forward to working with the talented teams across the Group to further develop our capabilities in advanced manufacturing, accelerate our customers’ time-to-market and build on Kaleidex’s strong momentum.”
About Kaleidex
Kaleidex is a leading Contract Manufacturing Organization (CMO) specialising in the design, development, and production of precision-engineered medical devices. With a strong commitment to innovation and collaboration, Kaleidex, backed by private equity firm Ansor, acquires and integrates high-performing medical manufacturing companies, building a network of expertise and innovation to drive industry advancements.